Skip to main content

The Orphan G-Protein Coupled Receptor 182 Is a Negative Regulator of Definitive Hematopoiesis through Leukotriene B4 Signaling

Publication ,  Journal Article
Kwon, HB; Mackie, DI; Bonnavion, R; Mercier, AL; Helker, CSM; Son, T; Guenter, S; Serafin, DS; Kim, KW; Offermanns, S; Caron, KM; Stainier, DYR
Published in: ACS Pharmacology and Translational Science
August 14, 2020

The G protein-coupled receptor 182 (GPR182) is an orphan GPCR, the expression of which is enriched in embryonic endothelial cells (ECs). However, the physiological role and molecular mechanism of action of GPR182 are unknown. Here, we show that GPR182 negatively regulates definitive hematopoiesis in zebrafish and mice. In zebrafish, gpr182 expression is enriched in the hemogenic endothelium (HE), and gpr182-/- display an increased expression of HE and hematopoietic stem cell (HSC) marker genes. Notably, we find an increased number of myeloid cells in gpr182-/- compared to wild-type. Further, by time-lapse imaging of zebrafish embryos during the endothelial-to-hematopoietic transition, we find that HE/HSC cell numbers are increased in gpr182-/- compared to wild-type. GPR182-/- mice also exhibit an increased number of myeloid cells compared to wild-type, indicating a conserved role for GPR182 in myelopoiesis. Using cell-based small molecule screening and transcriptomic analyses, we further find that GPR182 regulates the leukotriene B4 (LTB4) biosynthesis pathway. Taken together, these data indicate that GPR182 is a negative regulator of definitive hematopoiesis in zebrafish and mice, and provide further evidence for LTB4 signaling in HSC biology.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

ACS Pharmacology and Translational Science

DOI

EISSN

2575-9108

Publication Date

August 14, 2020

Volume

3

Issue

4

Start / End Page

676 / 689

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 3205 Medical biochemistry and metabolomics
  • 3101 Biochemistry and cell biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kwon, H. B., Mackie, D. I., Bonnavion, R., Mercier, A. L., Helker, C. S. M., Son, T., … Stainier, D. Y. R. (2020). The Orphan G-Protein Coupled Receptor 182 Is a Negative Regulator of Definitive Hematopoiesis through Leukotriene B4 Signaling. ACS Pharmacology and Translational Science, 3(4), 676–689. https://doi.org/10.1021/acsptsci.0c00020
Kwon, H. B., D. I. Mackie, R. Bonnavion, A. L. Mercier, C. S. M. Helker, T. Son, S. Guenter, et al. “The Orphan G-Protein Coupled Receptor 182 Is a Negative Regulator of Definitive Hematopoiesis through Leukotriene B4 Signaling.” ACS Pharmacology and Translational Science 3, no. 4 (August 14, 2020): 676–89. https://doi.org/10.1021/acsptsci.0c00020.
Kwon HB, Mackie DI, Bonnavion R, Mercier AL, Helker CSM, Son T, et al. The Orphan G-Protein Coupled Receptor 182 Is a Negative Regulator of Definitive Hematopoiesis through Leukotriene B4 Signaling. ACS Pharmacology and Translational Science. 2020 Aug 14;3(4):676–89.
Kwon, H. B., et al. “The Orphan G-Protein Coupled Receptor 182 Is a Negative Regulator of Definitive Hematopoiesis through Leukotriene B4 Signaling.” ACS Pharmacology and Translational Science, vol. 3, no. 4, Aug. 2020, pp. 676–89. Scopus, doi:10.1021/acsptsci.0c00020.
Kwon HB, Mackie DI, Bonnavion R, Mercier AL, Helker CSM, Son T, Guenter S, Serafin DS, Kim KW, Offermanns S, Caron KM, Stainier DYR. The Orphan G-Protein Coupled Receptor 182 Is a Negative Regulator of Definitive Hematopoiesis through Leukotriene B4 Signaling. ACS Pharmacology and Translational Science. 2020 Aug 14;3(4):676–689.

Published In

ACS Pharmacology and Translational Science

DOI

EISSN

2575-9108

Publication Date

August 14, 2020

Volume

3

Issue

4

Start / End Page

676 / 689

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 3205 Medical biochemistry and metabolomics
  • 3101 Biochemistry and cell biology